BusinessMidatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015By Nasdaq OMXApr 13, 2016, 6:00 AM UTC
BusinessMidatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in USBy Nasdaq OMXApr 11, 2016, 6:00 AM UTC
BusinessMidatech Pharma Recognises International Rare Disease Day 2016By Nasdaq OMXFeb 29, 2016, 7:00 AM UTC
BusinessMidatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading UpdateBy Nasdaq OMXJan 6, 2016, 7:00 AM UTC
